CDKN2B and acute lymphoblastic leukemia: Other than esophageal cancer, CDKN2B-AS1 had been linked to a variety of cancer types such as acute lymphoblastic leukemia [22], gastric cancer [20, 23] and hepatocellular carcinoma (HCC) [24].